Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Epirubicin in Advanced Gastric Cancer
NCT00075465Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Apr 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, epirubicin in gastric cancer (GC), sponsored by GERCOR. Status: unknown.
02
Drugs
docetaxelepirubicin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00075465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075465.